Response to comments on "PD-L1 expression and immune profiling cannot predict osimertinib efficacy in lung cancer with EGFR T790 M mutation: A translational study".
Journal
Journal of the Formosan Medical Association = Taiwan yi zhi
Journal Volume
125
Journal Issue
4
Start Page
488
End Page
489
ISSN
0929-6646
Date Issued
2026-04
Author(s)
Type
letter